Biocryst Pharmaceuticals Inc. (BCRX) Dividend History

BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014. It has also been approved in Japan, Korea and China The company was founded in 1986 by Charles E. Bugg, Ph.D. and John A. Montgomery, Ph.D. In March 1994, BioCryst became a public company when it completed an initial public offering by listing its shares on the NASDAQ stock exchange. In 2008 the company was named one of the fastest growing companies by Deloitte & Touche in its 2008 list of Technology Fast 500.

Last update 05/10/2021


Dividend Yield Summary

  2016 2017 2018 2019 2020 2021
Dividends - - - - - -
Average Price 4.18 5.75 6.29 5.01 4.06 10.49
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2021 are year-to-date.

DivInfo Metrics ™

52-Week Projected Earnings Per Share -1.09
52-Week Projected Dividends Per Share 0.00
Dividend Cover -
52-Week Projected Yield -
52-Week Trailing Yield -
6-Year Average Yield -
6-Year Dividend Change -
6-Year Yearly Dividend Change -
Number of Dividend Payments (2014-04-02 - 2014-06-11) 5

Dividend History

Date Amount Per Share Note
2014-06-11 $0.00
2014-06-05 $0.00
2014-05-20 $0.00
2014-05-16 $0.00
2014-04-02 $0.00